Search results
Results From The WOW.Com Content Network
Sigma-Aldrich (formally MilliporeSigma) [5] [6] is an American chemical, life science, and biotechnology company owned by the multinational chemical conglomerate Merck Group. Sigma-Aldrich was created in 1975 by the merger of Sigma Chemical Company and Aldrich Chemical Company.
By 1992, Sigma owned assets of $180 million, saw group sales turnover of $600 million and employed more than a thousand people. [2] By the end of the 20th century, Sigma had purchased the Guardian and Amcal retail pharmacy brands, and in 1999 listed on the Australian Stock Exchange as Sigma Pharmaceuticals Limited.
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
In 1952 Egypt’s private sector accounted for 76 percent of economic investment. Following the nationalization plans carried out by President Gamal Abdel Nasser in the effort to build a post-independence socialist state, this percentage drastically shifted within a few decades to government investment accounting for over 80 percent of economic investment. [1]
Location of Egypt. Egypt is a transcontinental country spanning the northeast corner of Africa and southwest corner of Asia by a land bridge formed by the Sinai Peninsula.Egypt's economy depends mainly on agriculture, media, petroleum imports, natural gas, and tourism; there are also more than three million Egyptians working abroad, mainly in Saudi Arabia, the Persian Gulf and Europe.
SEKEM's next initiative was the first private pharmaceutical company in Egypt, specializing in medicinal teas. The medical center had now grown to the point where it needed its own building; concurrently it considerably expanded its outreach into the Bedouin community, helping establish sanitary facilities and clean water supplies.
Leadiant Biosciences, formerly known as Sigma-Tau Industrie Farmaceutiche Riunite, was founded in 1957 [1] by research chemist Claudio Cavazza. In 2018 Leadiant Biosciences came under fire for creating a monopoly for CDCA and unnecessarily increasing the price by a factor of 335.
EMS Sigma Pharma - markets branded medicines; EMS Hospital - markets drugs to hospitals; EMS Consumer - markets OTC drugs. Today the company has a presence in over 30 countries through joint-ventures and strategic partnerships with other pharmaceutical companies. [2] EMS's Brazilian main competitors are Hypermarcas, Eurofarma, Aché and Cristália.